Detalles de la búsqueda
1.
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies.
Diabetologia
; 66(3): 415-424, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35867129
2.
Defining outcomes for ß-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.
Transpl Int
; 31(4): 343-352, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29453879
3.
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Diabetes
; 73(6): 823-833, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349844
4.
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.
Lancet Diabetes Endocrinol
; 11(12): 915-925, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931637
5.
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes.
Diabetes Care
; 45(10): 2189-2201, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150059
6.
Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes.
Patient Prefer Adherence
; 14: 1719-1731, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33061315
7.
Defining Outcomes for ß-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.
Transplantation
; 102(9): 1479-1486, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29528967
8.
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201.
Diabetes Care
; 45(12): 3113, 2022 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219765
Resultados
1 -
8
de 8
1
Próxima >
>>